List view / Grid view

COPD

 

3M Drug Delivery Systems relocates UK R&D to new, state-of-the-art facility

2 April 2019 | By

Environment plays a significant role in the way businesses ideate, communicate and create. While the global population is more connected than ever, there’s a certain level of collaboration that can only be achieved with proximity. To that end, 3M Drug Delivery Systems' (DDS) UK organisation is bringing its teams under…

Smartfish’s medical drink trial a success for COPD patients suffering from cachexia

20 September 2016 | By Niamh Louise Marriott, Digital Content Producer

Cachexia is a condition of involuntary weight loss, undernourishment and a number of negative side-effects that can be seen in patients with Chronic obstructive pulmonary disease (COPD), as well as in cancer and in several severe inflammatory diseases, such as AIDS, congestive heart failure, tuberculosis and rheumatoid arthritis...